IP Library Granted Patent US 10,112,001
Granted Patent B2
US 10,112,001 · App. 14/989,239 · Granted Oct 30, 2018

Method and composition for removing uremic toxins in dialysis processes

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,112,001
App. No.
14/989,239
Granted
Oct 30, 2018
Kind
B2
Abstract

A dialysis system comprising: a sorbent cartridge including a zirconium phosphate layer followed by at least one of a urease layer, a zirconium oxide layer, or a carbon layer; a pump in fluid communication sorbent cartridge; and a control unit in operable communication with the pump, wherein the control unit is programmed to cause the pump to pump a dialysis fluid to flow (i) in a first direction through the sorbent cartridge, wherein the zirconium phosphate layer is contacted by the dialysis fluid before the at least one of the urease layer, zirconium oxide layer or carbon layer and (ii) in a second direction through the sorbent cartridge wherein the at least one of the urease layer, zirconium oxide layer or carbon layer is contacted by the dialysis fluid before the zirconium phosphate layer.

Claims (13)

1. A method of performing dialysis comprising:

passing a dialysis fluid in a first flow direction through a sorbent cartridge in fluid communication with at least one of a patient or a dialyzer, the sorbent cartridge including a housing having a zirconium phosphate layer followed by at least one of a urease layer, a zirconium oxide layer, or a carbon layer, wherein the zirconium phosphate layer is first contacted by the dialysis fluid in the first flow direction before the at least one of the urease layer, zirconium oxide layer or carbon layer;

storing the dialysis fluid in a storage container; and

passing the dialysis fluid from the storage container back through the sorbent cartridge in a reverse flow direction from the first flow direction to reach the patient or the dialyzer.

2. The method of claim 1 , wherein the method is used to perform hemodialysis, hemofiltration, hemodiafiltration or peritoneal dialysis.

3. The dialysis method of claim 1 , which includes contacting the dialysis fluid with carbon first in the reverse flow direction.

4. The dialysis method of claim 1 , which includes contacting the dialysis fluid with urease as a secondary layer in the reverse flow direction.

5. The dialysis method of claim 1 , which includes contacting the dialysis fluid with zirconium oxide as a secondary layer in the reverse flow direction.

6. The dialysis method of claim 1 , wherein the zirconium phosphate layer is a first zirconium phosphate layer, and which includes contacting a second zirconium phosphate layer.

7. The dialysis method of claim 6 , wherein the housing includes a urease layer disposed between the first and second zirconium phosphate layers.

8. The dialysis method of claim 7 , wherein the housing includes the first zirconium phosphate layer, followed by the urease layer, followed by the second zirconium phosphate layer.

9. The dialysis method of claim 8 , wherein the housing includes the first zirconium phosphate layer, followed by the urease layer, followed by the second zirconium phosphate layer, followed by a zirconium oxide layer and/or a carbon layer.

10. The dialysis method of claim 9 , wherein the housing includes the first zirconium phosphate layer, followed by the urease layer, followed by the second zirconium phosphate layer, followed by the zirconium oxide layer, followed by the carbon layer.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2025
From: BAXTER HEALTHCARE SA
To: VANTIVE HEALTH GMBH
Reel/Frame 074042/0275 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 31, 2025
From: BAXTER INTERNATIONAL INC.
To: VANTIVE US HEALTHCARE LLC
Reel/Frame 074047/0140 →
SECURITY INTEREST Recorded Jan 31, 2025
From: VANTIVE US HEALTHCARE LLC; GAMBRO RENAL PRODUCTS, INC.
To: ARES CAPITAL CORPORATION
Reel/Frame 070076/0701 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 6, 2016
From: KAROOR, SUJATHA
To: BAXTER INTERNATIONAL INC.; BAXTER HEALTHCARE S.A.
Reel/Frame 038205/0662 →